The settlement resolves a lawsuit originally brought by three former Abbott employees under whistleblower protections.Naveen Athrappully
ReporterAbbott Laboratories has agreed to pay more than $384 million to settle allegations that it manufactured infant formula under conditions that posed a risk of contamination and then sold the products to federal and state programs, the U.S. Justice Department said on Monday.The settlement relates to a lawsuit originally filed by three whistleblower employees following a 2022 recall of Abbott baby formula products after complaints that they were contaminated with a potentially deadly bacterium. The Department of Justice partially intervened last year, filing a complaint in intervention in November.Specifically, Abbott was accus
